Product Program year 2025 Source: CMS Open Payments

General - Interventional Oncology

Device General - Interventional Oncology_PI

Open in the dashboard

General payments

$264,158

765 payments

Research payments

$0

0 payments

Through program year 2025, $264,158 in general payments and $0 in research payments were reported against General - Interventional Oncology (General - Interventional Oncology_PI).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $264,158 765

Breakdown

Who paid General payments · program year 2025
  1. Boston Scientific Corporation $264,158 765 payments
Top recipients General payments · program year 2025
  1. Siddharth Padia Vascular & Interventional Radiology · Los Angeles, CA $9,488 4% · 10 payments
  2. Sepideh Gholami Surgical Oncology · Sacramento, CA $8,348 3% · 3 payments
  3. Robert Lewandowski Vascular & Interventional Radiology · Chicago, IL $8,142 3% · 4 payments
  4. Jafar Golzarian Vascular & Interventional Radiology · Golden Valley, MN $8,038 3% · 4 payments
  5. Muneeb Ahmed Vascular & Interventional Radiology · Boston, MA $8,028 3% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular & Interventional Radiology Radiology $139,462 53% · 174 practitioners
  2. Diagnostic Radiology Radiology $22,722 9% · 103 practitioners
  3. Surgical Oncology Surgery $22,417 9% · 10 practitioners
  4. Hepatology Internal Medicine $15,505 6% · 3 practitioners
  5. Radiation Oncology Radiology $15,187 6% · 4 practitioners

The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $45,979 17% · 43 recipients
  2. Texas $30,305 11% · 17 recipients
  3. Illinois $25,001 9% · 110 recipients
  4. New York $21,616 8% · 16 recipients
  5. Indiana $14,937 6% · 3 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

765 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record